| Trial ID: | L4665 |
| Source ID: | NCT01471808
|
| Associated Drug: |
Csii
|
| Title: |
Effects of Different Early Intensive Therapies on Long-term β-cell Function
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: CSII|DRUG: CSII, Metformin, Pioglitazone|DRUG: CSII, Sitagliptin
|
| Outcome Measures: |
Primary: glycemic control after short intensive therapy in newly diagnosed type 2 diabetic patients, 1 years|the remission rate after short intensive therapy in newly diagnosed type 2 diabetic patients, 1 years | Secondary: the effects of different interventions on β-cell function in newly-diagnosed type 2 diabetic patients, 1 years
|
| Sponsor/Collaborators: |
Sponsor: Sun Yat-sen University | Collaborators: Nanfang Hospital, Southern Medical University|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Peking University Shenzhen Hospital|First People's Hospital of Foshan
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
264
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-10
|
| Completion Date: |
2018-12
|
| Results First Posted: |
|
| Last Update Posted: |
2024-08-16
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01471808
|
